Abstract
Cardiovascular diseases caused by atherosclerosis are one of the most important social and economic problems in many countries of the world due to the high morbidity and mortality rate of the working population. An immunological theory of atherosclerosis and coronary heart disease (CHD) has been actively developed of late, and markers of inflammation characterizing immuno- and atherogenesis have been sought. The buccal epithelium (BE) can be used as biological material for in vivo molecular-cellular studies, allowing CHD diagnosis via inflammation markers. The purpose of the work was a comparative study of the expression of IL-1β, IL-6, IL-10, MCP-1, and GDF-15 in BE in patients of different ages with CHD and without cardiovascular disease. The BE material in healthy donors and patients with second-stage CHD was divided into groups according to the age classification of the WHO: the first group included middle-aged people (45–59 years), and the second included elderly people (60–74 years). Control material was obtained from people of middle and old age without cardiovascular disease. According to the immunocytochemical study, the area of IL-1β expression in BE is three times higher in middle-aged CHD patients and 4.4 times higher in elderly people as compared to healthy individuals of the same age group. The area of IL-6 expression in middle-aged and elderly CHD patients was 7.9 and 7.4 times higher, respectively, than in the control group. In middle-aged and elderly CHD patients, the IL-10 expression was 1.6 and 2.8 times higher, respectively, as compared to healthy donors of the same age group. The MCP-1 expression in the BE of middle-aged and elderly people with and without ischemic heart disease did not differ. GDF-15 expression is 6.8 and 6.6 times higher in middle-aged and elderly CHD patients than in healthy people of the same age. The findings showed that the expression of the cytokines IL-1β, IL-6, IL-10, and GDF-15 increase in the BE of patients with CHD in middle-aged and elderly people as compared with persons of the same age group without cardiovascular disease. Thus, the BE can serve as an informative material for noninvasive molecular diagnosis of CHD in people of different ages.
Similar content being viewed by others
REFERENCES
Dzherieva, I.S., Volkova, N.I., and Rapoport, S.I., Association between depression and metabolic syndrome, Klin. Med., 2015, vol. 93, no. 1, pp. 62–65.
Zykov, K.A., Nuraliev, E.Yu., Kaznacheeva, E.I., et al., The dynamics of the inflammatory process in patients with acute coronary syndrome and stable angina pectoris. Part 2. Biochemical, immunological, and clinical aspects, Kardiol. Vestn., 2011, vol. 1, pp. 23–32.
Mironkov, B.L., Endovascular interventions in patients with heart transplant, Vestn. Transplantologii Iskusstv. Organov, 2015, vol. 17, no. 2, pp. 77–79.
Arponen, O., Muuronen, A., Taina, M., et al., Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke, PLoS One, 2015, vol. 10, no. 4, p. e0120910.
Berry, C., Fractional flow reserve, coronary flow reserve and the index of microvascular resistance in clinical practice, Radcliffe Cardiol., 2014, no. 3, pp. 1–6.
Bracey, N., Beck, P.L., Muruve, D., et al., The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β, Exp. Physiol., 2013, vol. 98, no. 2, pp. 462–472.
Cai, G., Zhang, B., Weng, W., et al., The associations between the MCP-1 -2518 A/G polymorphism and ischemic heart disease and ischemic stroke: a meta-analysis of 28 research studies involving 21,524 individuals, Mol. Biol. Rep., 2015, vol. 42, no. 5, pp. 997–1012.
Duffy, J.Y. and Hameed, A.B., Cardiovascular disease screening, Semin. Perinatol., 2015, vol. 39, no. 4, pp. 253–320.
Eggers, K.M., Kempf, T., and Allhoff, T., Growth-differentiation factor-15 for early risk stratifi cation in patients with acute chest pain, Eur. Heart J., 2008, vol. 29, no. 19, pp. 2327–2335.
Esquivias López-Cuervo, J., Montalbán Beltran, E., Cuadros Lopez, J.L., et al., Preliminary study of a new, fully automated system for liquid-based cytology: the NovaPrep® processor system, Acta Cytol., 2011, vol. 55, no. 3, pp. 281–286.
Gewirtz, H., Coronary circulation: pressure/flow parameters for assessment of ischemic heart disease, J. Nucl. Cardiol., 2019, vol. 26, no. 2, pp. 459–470. https://doi.org/10.1007/s12350-018-1270-3
Gould, K.L. and Johnson, N.P., Physiologic severity of diffuse coronary artery disease: hidden high risk, Circulation, 2015, vol. 131, pp. 4–6.
Gullestad, L., Ueland, T., and Vinge, L.E., Inflammatory cytokines in heart failure: mediators and markers, Cardiology, 2012, vol. 122, no. 1, pp. 23–35.
Jiang, X., Tian, W., Sung, Y.K., Qian, J., and Nicolls, M.R., Macrophages in solid organ transplantation, Vasc. Cell, 2014, vol. 6, p. 5.
Krishna, S.M., Moxon, J.V., and Golledge, J., A review of the pathophysiology and potential biomarkers for peripheral artery disease, Int. J. Mol. Sci., 2015, vol. 16, no. 5, pp. 11294–11322.
Ma, K., Chen, Y.X., and Wang, Y.Y., Impact of prostaglandin F2α and endothelin, pulsation index and resistance index of uterine artery blood flow on dysmenorrhea patients of cold stagnation and blood stasis syndrome with Dingkun Dan, Zhongguo Zhong Yao Za Zhi, 2017, vol. 42, no. 23, pp. 4474–4480.
Miteva, K., Madonna, R., De Caterina, R., and van Linthout, S., Innate and adaptive immunity in atherosclerosis, Vasc. Pharmacol., 2018. doi S1537-1891(17)30464-0
Schopfer, D.W., Ku, I.A., Regan, M., et al., Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study), Am. Heart J., 2014, vol. 167, no. 2, pp. 186–192.
Ye, F., Jin, X. Q., Chen, G.H., et al., Polymorphisms of interleukin-1 and interleukin-6 genes on the risk of ischemic stroke in a meta-analysis, Gene, 2012, vol. 499, no. 1, pp. 61–69.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The authors declare that they have no conflict of interest.
Statement of compliance with standards of research involving humans as subjects. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants involved in the study.
Additional information
Translated by P. Kuchina
Rights and permissions
About this article
Cite this article
Bunin, V.A., Karpasova, E.A., Kozhevnikova, E.O. et al. Prospects of the Application of Buccal Epithelium for Noninvasive Diagnosis of Coronary Heart Disease in People of Different Ages. Adv Gerontol 9, 261–265 (2019). https://doi.org/10.1134/S2079057019020061
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057019020061